ArticleCPT: pharmacometrics & systems pharmacology2019

Evaluation of the Drug-Drug Interaction Potential of Acalabrutinib and Its Active Metabolite, ACP-5862, Using a Physiologically-Based Pharmacokinetic Modeling Approach.

Diansong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.